Program

55
11
4
2
1
1
1
1

Journal Year Published

6
1
7
5
6
8
7
6
5
5

Author

56
182
174
134
134
125
118
116
114
108
88
86
81
73
51
50
43
43
42
34

Category

21
18
15
14
7
5
3
1
1

Keyword

32
15
15
13
11
10
10
9
8
8
7
7
7
6
6
6
6
6
5
5

Journal

9
6
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1

NCATS Publications

TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.


Jain M, Zhang L, He M, Zhang Y, Shen M, Kebebew E


Endocr. Relat. Cancer , (20), 361-70, 2013.

Article Pubmed

Sample image from publication page

A homogeneous, high-throughput assay for phosphatidylinositol 5-phosphate 4-kinase with a novel, rapid substrate preparation.


Davis MI, Sasaki AT, Shen M, Emerling BM, Thorne N, Michael S, Pragani R, Boxer M, Sumita K, Takeuchi K, Auld DS, Li Z, Cantley LC, Simeonov A


PLoS ONE , (8), e54127, 2013.

Article Pubmed

Sample image from publication page

Synthesis and biological evaluation of analogues of the kinase inhibitor nilotinib as Abl and Kit inhibitors.


Duveau D, Hu X, Walsh MJ, Shukla S, Skoumbourdis AP, Boxer MB, Ambudkar SV, Shen M, Thomas C


Bioorg. Med. Chem. Lett. , (23), 682-6, 2013.

Article Pubmed

Sample image from publication page

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.


Anastasiou D, et al.


Nat. Chem. Biol. , (8), 839-47, 2012.

Article Pubmed

Sample image from publication page

A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase.


Morgan HP, Walsh MJ, Blackburn EA, Wear MA, Boxer MB, Shen M, Veith H, McNae IW, Nowicki MW, Michels PA, Auld DS, Fothergill-Gilmore LA, Walkinshaw MD


Biochem. J. , (448), 67-72, 2012.

Article Pubmed

Sample image from publication page

Application of a homogenous membrane potential assay to assess mitochondrial function.


Sakamuru S, Li X, Attene-Ramos MS, Huang R, Lu J, Shou L, Shen M, Tice RR, Austin C, Xia M


Physiol. Genomics , (44), 495-503, 2012.

Article Pubmed

Sample image from publication page

Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDAS.


Zhu J, Choi WS, McCoy JG, Negri A, Zhu J, Naini S, Li J, Shen M, Huang W, Bougie D, Rasmussen M, Aster R, Thomas C, Filizola M, Springer TA, Coller BS


Sci Transl Med , (4), 125ra32, 2012.

Article Pubmed

Sample image from publication page